Mylan Institutional, Inc. recalls
7 recalls on record · FDA
Every recall we have on record for Mylan Institutional, Inc., compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.
Filter:
Health Serious
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister…
Super-Potent Drug: Out of specification potency results were obtained.
Mylan Institutional, Inc. Mar 26, 2025
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall
Health Serious
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit…
Subpotent and Superpotent Drug
Mylan Institutional, Inc. Dec 18, 2024
Read the recall